Accessibility Menu

enGene

(NASDAQ) ENGNW

Current Price$0.26
Market CapN/A
Since IPO (2022)-42%
5 YearN/A
1 Year-73%
1 Month-90%

enGene Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

-$122.44M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.85 (Low)

Price

$0.26

Volume

2,300

Open

$0.23

Previous Close

$0.25

Daily Range

$0.23 - $0.25

52-Week Range

$0.11 - $4.20

Estimated Earnings Date

Jun 12, 2026

ENGNW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About enGene

Industry

Biotechnology

Headquarters

Montreal, QC H4S 1Z9, CA

ENGNW Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-41%

Return on Assets

-36%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

0

Volume

2.30K

Avg. Volume

10.49K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$123.17M

EBITDA

-$113.80M

Operating Cash Flow

-$99.24M

Capital Expenditure

-$1.49M

Free Cash Flow

-$100.72M

Cash & ST Invst.

$193.82M

Total Debt

$31.80M

enGene Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$189.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

56

N/A

Net Income

-$29.75M

-20.9%

EBITDA

-$28.83M

-21.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$242.48M

+28.5%

Accounts Receivable

$1.20M

+178.4%

Inventory

$0.00

N/A

Long Term Debt

$30.96M

+34.4%

Short Term Debt

$2.51M

+19.0%

Return on Assets

-36.32%

N/A

Return on Invested Capital

-40.88%

N/A

Free Cash Flow

-$29.06M

-11.8%

Operating Cash Flow

-$28.90M

-12.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HYFTMindWalk Holdings Corp.
$1.67-0.89%
ALXOALX Oncology Holdings Inc.
$1.58+2.57%
BYSIBeyondSpring Inc.
$1.60-6.43%
CAMPCAMP4 Therapeutics Corporation
$4.19+1.93%

Trending Stocks

Symbol / CompanyPricePrice Chg
INHDInno
$6.64+5.32%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.63-0.06%
KEELKeel Infrastructure
$5.73+0.12%
LYGLloyds Banking Group Plc
$5.30-0.00%

Questions About ENGNW

What is the current price of enGene?

enGene is trading at $0.25 per share.

What is the 52-week range for enGene?

Over the past 52 weeks, enGene has traded between $0.11 and $4.20.

How much debt does enGene have?

enGene total debt is unavailable.

How much cash does enGene have on hand?

enGene does not have cash on hand data available.

What is enGene’s dividend yield?

enGene does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.